Novartis champions pre-pandemic vaccination programme
This article was originally published in Scrip
Executive Summary
One year on since the start of the swine flu outbreak, the cracks in our pandemic preparation strategy have become apparent. One solution, suggests Novartis's vice-president of influenza strategy Dr Klaus Stöhr, is pre-pandemic vaccination programmes.